Cipla Shares News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Cipla is aiming to transition from a pure-play pharma company to an integrated health player, per analysts.

Coming to the buildup of fresh short positions, When the stock prices move downward and open interest on the counter increases, it is taken as a sign of a short build-up. The signal is considered more reliable if the volume on the counter has also seen an increase as the stock price was declining.

Sumeet Bagadia of Choice Broking has chosen Cipla as his ‘Valentine's Day 2024 Pick’. Bagadia has recommended a ‘Buy’ on the pharma stock at ₹1,450 and up to ₹1,415 for a target price of ₹1,600 to ₹1,660.

For a large number of investors, volatility is something which is determined by what happened to the nifty by the end of the day and they associate it with decline in indices. But there is more to it, on Tuesday, because there was a decline, it might appear to be volatile. But the fact is on wednesday because Nifty and Sensex recovered and gained back the losses, these two days together make it a volatile market. The reason to bring this upfront is that when valuations are high and the market turns volatile, the cut on the individual stock prices can be much higher. So, if one is increasing th...

Samina is the niece of Cipla non-executive chairman YK Hamied, and daughter of his brother and non-executive vice-chairman, MK Hamied. The company said she would continue as a non-executive director.